Hub: Tech for Good - Page 4
Stories from Hub: Tech for Good come first, newest first, then stories from connected topics (AI Science & Health, AI for science, Biotech, drug discovery, protein design, Healthcare), each labelled with where it comes from. This view is not indexed by search engines.
Latest
Meta, 14 Other Tech Companies and Law Enforcement Disrupt Scam Networks in West Africa
Meta and 14 other tech companies joined police from ten countries against West African scam networks. Law enforcement confirmed 28 arrests, Meta says.
Seqera Launches Nextflow Frontier, an AI System That Runs Thousands of Biology Experiments
Seqera has launched Nextflow Frontier, an AI system that runs thousands of biology experiments. Its benchmark results are Seqera's own claims.
Google DeepMind’s AlphaProof Nexus Is Published in Science: 9 of 353 Erdős Problems, 44 of 492 OEIS Conjectures, by the Authors’ Own Account
DeepMind's AlphaProof Nexus is in Science. Its authors report 9 of 353 Erdős problems and 44 of 492 OEIS conjectures proved. What that means, and the limits.
Type One Energy Raises $200 Million for Stellarator Fusion, but Groundbreaking Slips to 2027
Type One Energy says it has completed a $200 million Series B, co-led by Breakthrough Energy Ventures and Clutterbuck Capital, to fund its stellarator fusion programme in Tennessee. What the money is for, which timeline claims are the company's own, and why groundbreaking has slipped to the first half of 2027.
AI in Medicine: Google’s AMIE in The Lancet, Chai and GSK, and an FDA-Cleared Autism Assessment Aid
Three AI-in-medicine items from 8–9 October 2026: a peer-reviewed Lancet feasibility study of Google's AMIE chatbot in real primary care, a company-announced collaboration between Chai Discovery and GSK on AI-designed proteins, and FDA clearance for Argus Cognitive's Neurora, an aid for clinicians that is not a stand-alone diagnostic tool. What each shows, and its limits.
Multiply Labs’ $75M Series B: robots between AI discovery and patient doses
Multiply Labs’ company release says it raised $75 million in Series B funding led by Patrick Soon-Shiong’s NantWorks to scale robotic GMP manufacturing clusters for biologics, bringing total capital raised to over $100 million.
UK healthcare AI: all 44 recommendations accepted, Airlock Phase 3 opens
The UK government said it will accept all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, and the MHRA opened AI Airlock Phase 3 applications focused on post-market surveillance.
The Invisible Signature: Google DeepMind Has Started Watermarking AI-Designed Proteins
A new Nature paper shows you can hide a made-by-AI tag inside a designed protein without breaking it. The researchers also say the tag can still be wiped off.
You Can Now Sequence the Human Genome on a Mac Mini
In October 2024, Apple launched the new Mac Mini M4 — a $599 desktop that fits in the palm of your hand. In the same breath, they...
The Drug Was Designed by an AI: How Insilico and Lilly Just Changed Medicine Forever
Something remarkable is happening in a lab you've never heard of, funded by a deal that barely made the news cycle. Last week, Eli Lilly — one...
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.